Get started
Jaguar Health, Inc.Jaguar Health, Inc.Jaguar Health, Inc.

Jaguar Health, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

JAGX chart


Full chart

JAGX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪12.27 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−16.10 USD
Net income (FY)
‪−41.30 M‬ USD
Revenue (FY)
‪9.76 M‬ USD
Shares float
‪7.71 M‬
Beta (1Y)
−1.07

Employees


Employees (FY)
49
Change (1Y)
−11 −18.33%
Revenue / Employee (1Y)
‪199.20 K‬ USD
Net income / Employee (1Y)
‪−842.86 K‬ USD

About Jaguar Health, Inc.


Sector
Health Technology
CEO
Lisa A. Conte
Headquarters
San Francisco
Website
jaguar.health
Founded
2013
FIGI
BBG005Z20406
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

JAGX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of JAGX is 1.04 USD — it has increased by 5.62% in the past 24 hours. Watch Jaguar Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jaguar Health, Inc. stocks are traded under the ticker JAGX.
JAGX stock has fallen by −1.89% compared to the previous week, the month change is a −11.86% fall, over the last year Jaguar Health, Inc. has showed a −95.19% decrease.
We've gathered analysts' opinions on Jaguar Health, Inc. future price: according to them, JAGX price has a max estimate of 6.00 USD and a min estimate of 6.00 USD. Watch JAGX chart and read a more detailed Jaguar Health, Inc. stock forecast: see what analysts think of Jaguar Health, Inc. and suggest that you do with its stocks.
JAGX reached its all-time high on May 13, 2015 with the price of 99,326,998.33 USD, and its all-time low was 0.90 USD and was reached on Nov 11, 2024. View more price dynamics on JAGX chart.
See other stocks reaching their highest and lowest prices.
JAGX stock is 9.02% volatile and has beta coefficient of −1.07. Track Jaguar Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Jaguar Health, Inc. there?
Today Jaguar Health, Inc. has the market capitalization of ‪9.61 M‬, it has increased by 2.57% over the last week.
Yes, you can track Jaguar Health, Inc. financials in yearly and quarterly reports right on TradingView.
Jaguar Health, Inc. is going to release the next earnings report on Apr 15, 2025. Keep track of upcoming events with our Earnings Calendar.
JAGX earnings for the last quarter are −1.05 USD per share, whereas the estimation was −2.37 USD resulting in a 55.70% surprise. The estimated earnings for the next quarter are −0.74 USD per share. See more details about Jaguar Health, Inc. earnings.
Jaguar Health, Inc. revenue for the last quarter amounts to ‪3.07 M‬ USD, despite the estimated figure of ‪3.90 M‬ USD. In the next quarter, revenue is expected to reach ‪3.10 M‬ USD.
JAGX net income for the last quarter is ‪−9.85 M‬ USD, while the quarter before that showed ‪−9.49 M‬ USD of net income which accounts for −3.81% change. Track more Jaguar Health, Inc. financial stats to get the full picture.
No, JAGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 49.00 employees. See our rating of the largest employees — is Jaguar Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Jaguar Health, Inc. EBITDA is ‪−27.50 M‬ USD, and current EBITDA margin is −323.04%. See more stats in Jaguar Health, Inc. financial statements.
Like other stocks, JAGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jaguar Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Jaguar Health, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Jaguar Health, Inc. stock shows the sell signal. See more of Jaguar Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.